Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers
Recruiting
Observational Study
Malignant Female Reproductive System Neoplasm
Metastatic Malignant Female Reproductive System Neoplasm
Unresectable Malignant Female Reproductive System Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Fred Hutchinson Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is being done to determine how easy it is to use standard of care (SOC) surgical resections or biopsy for SmartMatch analysis to determine treatment options in advanced gynecological malignancies.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Histologically confirmed rare gynecologic malignancy, including but not limited to those listed
* Metastatic or unresectable disease, OR disease for which additional systemic therapy is indicated
* Fresh tumor tissue available from a SOC surgical procedure or …
Contacts